Are Tpo agonists an option for ITP in pregnancy?

Abstract

In this issue of Blood, Michel and colleagues provide a multi-institutional, retrospective, and observational study on the use of thrombopoietin receptor agonists (Tpo-RAs) in the management of severe thrombocytopenia in pregnant immune thrombocytopenia (ITP) women refractory to standard therapies.